FR1521076A - Nucléosides de purines substituées - Google Patents

Nucléosides de purines substituées

Info

Publication number
FR1521076A
FR1521076A FR104388A FR104388A FR1521076A FR 1521076 A FR1521076 A FR 1521076A FR 104388 A FR104388 A FR 104388A FR 104388 A FR104388 A FR 104388A FR 1521076 A FR1521076 A FR 1521076A
Authority
FR
France
Prior art keywords
substituted purine
purine nucleosides
nucleosides
substituted
purine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR104388A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to FR104388A priority Critical patent/FR1521076A/fr
Application granted granted Critical
Publication of FR1521076A publication Critical patent/FR1521076A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
FR104388A 1966-05-02 1967-04-27 Nucléosides de purines substituées Expired FR1521076A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR104388A FR1521076A (fr) 1966-05-02 1967-04-27 Nucléosides de purines substituées

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54653166A 1966-05-02 1966-05-02
FR104388A FR1521076A (fr) 1966-05-02 1967-04-27 Nucléosides de purines substituées

Publications (1)

Publication Number Publication Date
FR1521076A true FR1521076A (fr) 1968-04-12

Family

ID=26175990

Family Applications (1)

Application Number Title Priority Date Filing Date
FR104388A Expired FR1521076A (fr) 1966-05-02 1967-04-27 Nucléosides de purines substituées

Country Status (1)

Country Link
FR (1) FR1521076A (fr)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090121A3 (fr) * 2000-05-23 2002-05-02 Novirio Pharmaceuticals Ltd Methodes et compositions permettant de traiter le virus de l'hepatite c
WO2001092282A3 (fr) * 2000-05-26 2002-05-02 Novirio Pharmaceuticals Ltd Procedes et compositions de traitement des flavivirus et des pestivirus
WO2003093290A3 (fr) * 2002-05-06 2004-03-18 Genelabs Tech Inc Derives nucleosidiques destines au traitement de l'infection par le virus de l'hepatite c
WO2004002999A3 (fr) * 2002-06-28 2004-08-12 Idenix Cayman Ltd Promedicaments a nucleosides 2' et 3' destines a traiter les infections aux flavivirus
US7192936B2 (en) 2002-06-28 2007-03-20 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7456155B2 (en) 2002-06-28 2008-11-25 Idenix Pharmaceuticals, Inc. 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7582618B2 (en) 2002-06-28 2009-09-01 Idenix Pharmaceuticals, Inc. 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7598373B2 (en) 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
US7824851B2 (en) 2002-11-15 2010-11-02 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001090121A3 (fr) * 2000-05-23 2002-05-02 Novirio Pharmaceuticals Ltd Methodes et compositions permettant de traiter le virus de l'hepatite c
US10758557B2 (en) 2000-05-23 2020-09-01 Idenix Pharmaceuticals Llc Methods and compositions for treating hepatitis C virus
US10363265B2 (en) 2000-05-23 2019-07-30 Idenix Pharmaceuticals Llc Methods and compositions for treating hepatitis C virus
US8299038B2 (en) 2000-05-23 2012-10-30 Idenix Pharmaceuticals, Inc. Methods and compositions for treating hepatitis C virus
SG156517A1 (en) * 2000-05-23 2009-11-26 Idenix Cayman Ltd Methods and compositions for treating hepatitis c virus
EA007178B1 (ru) * 2000-05-23 2006-08-25 Айденикс (Кайман) Лимитед Производные beta-d-нуклеозида в качестве лекарственного средства для лечения инфекции вируса гепатита c у хозяина
US7608597B2 (en) 2000-05-23 2009-10-27 Idenix Pharmaceuticals, Inc. Methods and compositions for treating hepatitis C virus
EA011720B1 (ru) * 2000-05-23 2009-04-28 Айденикс (Кайман) Лимитед ПРОИЗВОДНЫЕ β-D-НУКЛЕОЗИДА И ИХ ПРИМЕНЕНИЕ
US7157441B2 (en) 2000-05-23 2007-01-02 Idenix Pharmaceuticals, Inc. Methods and compositions for treating hepatitis C virus
EP1736478A1 (fr) * 2000-05-26 2006-12-27 Idenix (Cayman) Limited Procédés et compositions de traitement des flavivirus et des pestivirus
US8343937B2 (en) 2000-05-26 2013-01-01 Idenix Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses
US7163929B2 (en) 2000-05-26 2007-01-16 Idenix Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses
EA007867B1 (ru) * 2000-05-26 2007-02-27 Айденикс (Кайман) Лимитед Композиции для лечения флавивирусных и пестивирусных инфекций и способы их применения
AP1727A (en) * 2000-05-26 2007-03-06 Idenix Cayman Ltd Methods and compositions for treating flaviviruses and pestiviruses.
WO2001092282A3 (fr) * 2000-05-26 2002-05-02 Novirio Pharmaceuticals Ltd Procedes et compositions de traitement des flavivirus et des pestivirus
US9968628B2 (en) 2000-05-26 2018-05-15 Idenix Pharmaceuticals Llc Methods and compositions for treating flaviviruses and pestiviruses
US7148206B2 (en) 2000-05-26 2006-12-12 Idenix Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses
US6812219B2 (en) 2000-05-26 2004-11-02 Idenix Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses
US7105493B2 (en) 2000-05-26 2006-09-12 Idenix Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses
US7101861B2 (en) 2000-05-26 2006-09-05 Indenix Pharmaceuticals, Inc. Methods and compositions for treating flaviviruses and pestiviruses
WO2003093290A3 (fr) * 2002-05-06 2004-03-18 Genelabs Tech Inc Derives nucleosidiques destines au traitement de l'infection par le virus de l'hepatite c
US7635689B2 (en) 2002-06-28 2009-12-22 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7547704B2 (en) 2002-06-28 2009-06-16 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7456155B2 (en) 2002-06-28 2008-11-25 Idenix Pharmaceuticals, Inc. 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7625875B2 (en) 2002-06-28 2009-12-01 Idenix Pharmaceuticals, Inc. 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
EP2799442A1 (fr) * 2002-06-28 2014-11-05 IDENIX Pharmaceuticals, Inc. Promédicaments à base de nucléosides modifiés en 2' et 3' pour le traitement d'infections par flavivirus
US7662798B2 (en) 2002-06-28 2010-02-16 Idenix Pharmaceuticals, Inc. 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7192936B2 (en) 2002-06-28 2007-03-20 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7365057B2 (en) 2002-06-28 2008-04-29 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections
WO2004002999A3 (fr) * 2002-06-28 2004-08-12 Idenix Cayman Ltd Promedicaments a nucleosides 2' et 3' destines a traiter les infections aux flavivirus
US7384924B2 (en) 2002-06-28 2008-06-10 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7582618B2 (en) 2002-06-28 2009-09-01 Idenix Pharmaceuticals, Inc. 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US8674085B2 (en) 2002-11-15 2014-03-18 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
US7824851B2 (en) 2002-11-15 2010-11-02 Idenix Pharmaceuticals, Inc. 2′-branched nucleosides and Flaviviridae mutation
US10525072B2 (en) 2002-11-15 2020-01-07 Idenix Pharmaceuticals Llc 2′-branched nucleosides and flaviviridae mutation
US7598373B2 (en) 2002-12-12 2009-10-06 Idenix Pharmaceuticals, Inc. Process for the production of 2-C-methyl-D-ribonolactone
US7781576B2 (en) 2005-12-23 2010-08-24 Idenix Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides

Similar Documents

Publication Publication Date Title
CH445343A (de) Feuerwaffe
AT270921B (de) Systembauteile
AT284727B (de) Abwurfanlage
CH438097A (de) Handfeuerwaffe
IL34301A0 (en) Pyrimidine nucleosides
BE785575A (fr) Nucleosides de la purine
FR1511251A (fr) Servo-mécanisme
AT303490B (de) Drehmaschine
FR1521076A (fr) Nucléosides de purines substituées
CH459332A (de) Schaltwerk
PH9966A (en) 2-thio-pyrimidine nucleoside
FR1513739A (fr) Dérivés pyrimidiniques
FR1491235A (fr) Générateur de choc
CH443931A (de) Gleitfahrzeug
FR1508828A (fr) Porte-objets
FR1513668A (fr) Lambrissage
DOP1967001364A (es) Sustitutos de 2-aminobenzimidazoles
AT262776B (de) Gleitfahrzeug
CH450250A (de) Skivorderteil
FR1512415A (fr) Cendrier
FR1469978A (fr) Structure de revêtement
FR1502040A (fr) Fontaine lumineuse pyrotechnique
FR1492857A (fr) Porte-boule
IE31801L (en) Adenosine derivatives
IE31310L (en) Adenosine derivatives